GlaxoSmithKline Pharma to invest Rs 1,000 crore in new unit in Karnataka

10 Jul 2017 Evaluate

GlaxoSmithKline Pharmaceuticals is investing Rs 1,000 crore in a new state-of-the-art pharmaceutical unit located at Vemgal in state of Karnataka and is looking at enhancing its global pipeline in areas like respiratory drugs and vaccines in India.

The factory will initially supply a range of solid dose form products. The factory will commence production in 2018 and produce more than 8 billion tablets and 1 billion capsules a year.

GlaxoSmithKline Pharmaceuticals is a subsidiary of GlaxoSmithKline plc, one of the world's leading research-based pharmaceutical and healthcare companies, committed to improving the quality of human life by enabling people to do more, feel better and live longer. 



Glaxosmithkline Phar Share Price

2380.90 3.25 (0.14%)
20-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.45
Dr. Reddys Lab 1298.95
Cipla 1255.85
Zydus Lifesciences 890.60
Lupin 2322.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×